Precision Medicine

Cleveland Clinic COVID-19 research effort to rely on EHRs, analytics

The main campus of the Cleveland Clinic.

By Fred Bazzoli 10:30 am April 24, 2020
The organization, looking for ways to treat pathogens, will mine electronic health records of COVID-19 patients and use analytics to expedite research to find optimal treatment approaches.
By Mike Miliard 03:48 pm April 17, 2020
"We see an enormous opportunity to enhance disease tracking for improved population health during the COVID-19 pandemic," said Scripps Research Translational Institute's Dr. Eric Topol.
By Dean Koh 03:08 am February 19, 2020
Update: The HIMSS Global Conference in Orlando has been canceled due to the coronavirus. Read more here.
By Jonah Comstock 07:00 am February 18, 2020
The pilot showcases an approach to AI integration that keeps impact on the radiologist's workflow to a minimum.
By Benjamin Harris 10:55 am February 10, 2020
Update: HIMSS20 has been canceled due to the coronavirus. Read more here.
By Mike Miliard 02:26 pm January 30, 2020
The five-year project will focus on enabling faster medical research innovations, protecting against global health crises and improving access to care, the company says.
By Nathan Eddy 10:57 am January 23, 2020
Artificial intelligence will also continue to be a big focus, as it becomes more clear which startups are succeeding in their initial target sectors. VCs are also eyeing genomics analytics tools, as well as other more practical technologies.

Credit: NUS

By Dean Koh 12:32 am January 15, 2020
“This is a big step forward in personalizing cancer treatment and ensuring better patient outcomes,” said Professor Lim Chwee Teck, Mechanobiology Institute, NUS Biomedical Engineering.
By Mike Miliard 03:48 pm January 14, 2020
Masimo, the maker of monitoring technologies and connectivity tools for hospitals, announced this week that it will acquire the connected care assets of NantHealth for $47.25 million in cash.
By Nathan Eddy 12:18 pm January 10, 2020
The findings suggest AI systems can be trained to detect and grade cancer in prostate needle biopsy samples with an accuracy rate equal to that of prostate pathology experts.